US FDA approves Idorsia’s once-daily TRYVIO (aprocitentan)
Ad hoc announcement pursuant to Art. 53 LR TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with ...
Read moreAd hoc announcement pursuant to Art. 53 LR TRYVIO™ (aprocitentan) is indicated for the treatment of hypertension in combination with ...
Read more19 March 2024 – Today, during the first day of its meeting at Olympic House in Lausanne, the International Olympic ...
Read more19 March 2024 – Following the disqualification of two athletes from the London 2012 weightlifting competitions and the change of ...
Read more18 January 2024 - One change of nationality for an athlete, and the Guidelines that clarify the opportunities for athlete ...
Read moreSubcutaneous (SC) injection offers the potential for a faster, more convenient alternative to intravenous (IV) infusion and is preferred by ...
Read moreZORYVE foam represents a highly effective, safe, well-tolerated, once-daily steroid-free foam for use on all affected areas of the body, ...
Read more08 December 2023 - The Executive Board (EB) of the International Olympic Committee (IOC) has decided that Individual Neutral Athletes ...
Read moreWEIPA, Australia--(BUSINESS WIRE)--Rio Tinto has approved a new 12.4MW solar farm and 8.8MVa/2.1MWh of battery storage to provide renewable energy ...
Read moreFollowing the IOC Executive Board (EB)’s approval of the discipline programme and the IOC Session decisions taken in October 2023 on Organising Committee-proposed ...
Read moreThe qualification systems for Alpine skiing, bobsleigh and skeleton for the Olympic Winter Games Milano Cortina 2026 have been approved ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.